Price: 3499 USD
Availability: InStock
Rating: 4.5 (94 reviews)
Author: Exactitude Consultancy
ISBN: 2915

Descripción general del mercado de terapias gastrointestinales

Se espera que el mercado mundial de terapias gastrointestinales crezca a una tasa anual compuesta del 8,6 % entre 2020 y 2029. Se espera que alcance más de 48 600 millones de dólares en 2029, frente a los 20 400 millones de dólares en 2020.

La terapéutica gastrointestinal constituye un campo especializado dentro del campo médico dedicado al diagnóstico y tratamiento de enfermedades que afectan al tracto gastrointestinal. Esta rama de la medicina se concentra en abordar trastornos que afectan a órganos ubicados dentro del sistema gastrointestinal, que abarcan el estómago, el intestino delgado, el intestino grueso y el recto. La terapéutica gastrointestinal abarca un espectro de intervenciones, incluidos productos farmacéuticos destinados a mitigar los síntomas, mejorar la funcionalidad general del sistema gastrointestinal y mejorar la calidad de vida de las personas afectadas por dichas afecciones.

[título id="attachment_4435" align="aligncenter" width="870"]

Gastrointestinal Therapeutics Market | Exactitude Consultancy

Mercado de terapias gastrointestinales | Exactitude Consultancy[/subtítulo]

El aumento de la prevalencia de trastornos gastrointestinales como la enfermedad por reflujo gastroesofágico (ERGE), la enfermedad inflamatoria intestinal (EII), el síndrome del intestino irritable (SII) y los cánceres gastrointestinales es un factor principal que impulsa la expansión del mercado. Factores contribuyentes como los malos hábitos alimentarios, los estilos de vida sedentarios y las influencias ambientales exacerban el aumento de las tasas de incidencia, fomentando así una demanda sostenida de tratamientos eficaces y apoyando el crecimiento del mercado. Por ejemplo, una publicación de la National Stem Cell Foundation en 2023 reveló que casi el 4% de la población mundial se ve afectada por una o más de más de 80 enfermedades autoinmunes distintas, incluidas afecciones prevalentes como la diabetes tipo 1, la esclerosis múltiple, la artritis reumatoide, el lupus, la enfermedad de Crohn, la psoriasis y la esclerodermia.

La creciente carga de enfermedades gastrointestinales entre la población subraya la necesidad de productos farmacéuticos eficaces, por lo que se espera que impulsen la expansión del mercado. Por ejemplo, según las estadísticas publicadas por la Sociedad Estadounidense del Cáncer en 2023, aproximadamente 153.020 personas fueron diagnosticadas con cáncer colorrectal (CCR), incluidas 19.550 personas menores de 50 años. Además, la actualización de 2023 de Bowel Cancer United Kingdom destaca el cáncer de intestino como el cuarto cáncer más prevalente, con aproximadamente 47.700 nuevos casos diagnosticados anualmente en el Reino Unido. Además, como se indica en un artículo publicado en la Biblioteca Nacional de Medicina en julio de 2022, la enfermedad por reflujo gastroesofágico (ERGE), el trastorno gastrointestinal más prevalente, afecta al 20% de las personas en las culturas occidentales.

[título id="attachment_4250" align="aligncenter" width="680"]

Mercado de terapias gastrointestinales | Exactitude Consultancy[/subtítulo]

Gastrointestinal Therapeutics Market Segment Analysis

In terms of application, the ulcerative colitis sector is predicted to contribute significantly to the gastrointestinal therapeutics market through 2028. The chronic idiopathic inflammatory condition of the gastrointestinal system mostly affects the mucosal lining of the colon. According to current research, the incidence of gastrointestinal disorders is growing in many regions of the world as a result of greater access to health care, changed lifestyles, and higher rates of industrialization and sanitation. A number of institutes are now investigating novel and promising medicinal techniques, which are projected to drive expansion in the approaching years.

Because of the increasing need for innovative therapeutics for a variety of difficult conditions, the gastrointestinal therapeutics Market Size is predicted to rise at a respectable rate between 2022 and 2028. Motility disorders, IBD, diarrheal disorders, constipation, and iatrogenic illnesses such as visceral discomfort, surgical ileus, GERD, and other esophageal problems are examples of these. Pharmacokinetics, specific diets, opioid mechanisms of drug tolerance, and the interaction between gut microbiota and pharmacotherapy, microRNA's, constipation, purinergic medicines, and others are emerging fields in the field of GI treatments.

Gastrointestinal Therapeutics Market Players

From large companies to small ones, many companies are actively working in the gastrointestinal therapeutics market. These key players include Abbott Laboratories, Johnson & Johnson, AbbVie Inc., Salix Pharmaceuticals, GlaxoSmithKline Plc., ALLERGAN, Takeda Pharmaceutical Company Limited, AstraZeneca, Astellas Pharma US, Inc., and Pfizer Inc and others.

Companies are mainly gastrointestinal therapeutics they are competing closely with each other. Innovation is one of the most important key strategies as it has to be for any market. However, companies in the market have also opted and successfully driven inorganic growth strategies like mergers & acquisitions, and so on.

In February 2021, Dr Reddy's Laboratories launched Lansoprazole delayed-release orally disintegrating tablets in the United States.
In March 2020, Sebela Pharmaceuticals received approval from the United States Food and Drug Administration (FDA) for Pizensy (lactitol) in the treatment of chronic idiopathic constipation (CIC) in adults. Penny is an osmotic laxative that works by causing the influx of water into the small intestine leading to a laxative effect in the colon.

Who Should Buy? Or Key Stakeholders

Suppliers
Manufacturing Companies
End-user companies
Research institutes
Hospitals

Key Takeaways:

The global gastrointestinal therapeutics market is expected to grow at 8.6% CAGR.
In terms of application, the ulcerative colitis sector is predicted to contribute significantly to the gastrointestinal therapeutics market
According to current research, the incidence of gastrointestinal disorders is growing in many regions.
Global gastrointestinal therapeutics market major share is occupied by North America.
The gastrointestinal therapeutics market is experiencing growth driven by the rising prevalence of gastrointestinal disorders and the introduction of advanced treatment options.

Gastrointestinal Therapeutics Market Regional Analysis

The gastrointestinal therapeutics market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

Its major share is occupied by North America, Asia Pacific, and Europe the region. North America shares 27% of the total market.

[caption id="attachment_4254" align="alignleft" width="680"]

Gastrointestinal Therapeutics Market | Exactitude Consultancy[/caption]

Key Market Segments: Gastrointestinal Therapeutics Market

Gastrointestinal Therapeutics Market by Type, 2020-2029, (USD Million)

Prescription Based Gastrointestinal Therapeutics
Otc Gastrointestinal Therapeutics

Gastrointestinal Therapeutics Market by Application, 2020-2029, (USD Million)

Gastroenteritis
Gi Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (Pud)

Gastrointestinal Therapeutics Market by Dosage Forms, 2020-2029, (USD Million)

Oral
Injections

Gastrointestinal Therapeutics Market by End User, 2020-2029, (USD Million)

Hospitals
Clinics

Gastrointestinal Therapeutics Market by Region, 2020-2029, (USD Million)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered.

Key Question Answered

What are the growth opportunities related to the adoption of gastrointestinal therapeutics across major regions in the future?
What are the new trends and advancements in the gastrointestinal therapeutics market?

Which product categories are expected to have the highest growth rate in the gastrointestinal therapeutics market?

Which are the key factors driving the gastrointestinal therapeutics market?
What will the market growth rate, growth momentum, or acceleration the market carries during the forecast period?

Introducción
1. Definición de mercado
2. Segmentación del mercado
3. Cronología de la investigación
4. Supuestos y limitaciones

Metodología de la investigación
1. Minería de datos
  1. Investigación secundaria
  2. Investigación primaria
  3. Asesoramiento de expertos en la materia
2. Controles de calidad
  1. Revisión final
3. Triangulación de datos
  1. Enfoque de abajo hacia arriba
  2. Enfoque de arriba hacia abajo
  3. Flujo de investigación
4. Fuentes de datos

Resumen ejecutivo

Descripción general del mercado
1. Perspectivas del mercado mundial de terapias gastrointestinales
  1. Factores impulsores del mercado
  2. Restricciones del mercado
  3. Oportunidades de mercado
2. Impacto de la COVID-19 en el mercado mundial de terapias gastrointestinales

Mercado mundial de terapias gastrointestinales por formas farmacéuticas (millones de USD)
1. Oral
2. Inyecciones

Mercado mundial de terapias gastrointestinales por tipo (millones de USD)
1. Terapéutica gastrointestinal basada en prescripción médica
2. Terapias gastrointestinales de venta libre

Mercado mundial de terapias gastrointestinales por aplicación (millones de USD)
1. Gastroenteritis
2. Sangrado gastrointestinal
3. Síndrome del intestino irritable
4. Enfermedad ulcerosa péptica (EUP)

Mercado mundial de terapias gastrointestinales por usuario final (millones de USD)
1. Hospitales
2. Clínicas

Mercado mundial de terapias gastrointestinales por región (millones de USD)
1. Introducción
2. Asia-Pacífico
  1. Porcelana
  2. India
  3. Japón
  4. Corea del Sur
  5. Australia
  6. Sudeste asiático
  7. Resto de Asia-Pacífico
3. América del norte
  1. Estados Unidos
  2. Canadá
  3. México
4. Europa
  1. Alemania
  2. Reino Unido
  3. Francia
  4. Italia
  5. España
  6. Rusia
  7. Resto de Europa
5. Sudamerica
  1. Brasil
  2. Argentina
  3. Colombia
  4. Resto de Sudamérica
6. Oriente Medio y África
  1. Emiratos Árabes Unidos
  2. Arabia Saudita
  3. Sudáfrica
  4. Resto de Oriente Medio y África

Perfiles de empresas* (descripción general de la empresa, descripción general de la empresa, formas de dosificación ofrecidas, desarrollos recientes)
1. Laboratorios Abbott
2. Johnson y Johnson
3. Compañía: AbbVie Inc.
4. Productos farmacéuticos Salix
5. Compañía: GlaxoSmithKline Ltd.
6. ALERGÁN
7. Compañía farmacéutica Takeda limitada
8. AstraZeneca
9. Astellas Pharma USInc.

*La lista de empresas es orientativa

LISTA DE TABLAS

TABLE 1                 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 2                 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 3                 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 4                 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 5                 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 6                 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 7                 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 8                 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 9                 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY REGION (USD MILLIONS), 2020-2029

TABLE 10                GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY REGION (THOUSAND UNIT), 2020-2029

TABLE 11                NORTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 12                NORTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (THOUSAND UNIT), 2020-2029

TABLE 13                US GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 14                US GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 15                US GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 16                US GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 17                US GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 18                US GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 19                US GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 20                US GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 21                CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 22                CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 23                CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 24                CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 25                CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 26                CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 27                CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 28                CANADA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 29                MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 30                MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 31                MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 32                MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 33                MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 34                MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 35                MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 36                MEXICO GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 37                SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 38                SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (THOUSAND UNIT), 2020-2029

TABLE 39                BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (BRAZILD MILLIONS), 2020-2029

TABLE 40                BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 41                BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (BRAZILD MILLIONS), 2020-2029

TABLE 42                BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 43                BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (BRAZILD MILLIONS), 2020-2029

TABLE 44                BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 45                BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (BRAZILD MILLIONS), 2020-2029

TABLE 46                BRAZIL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 47                ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 48                ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 49                ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 50                ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 51                ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 52                ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 53                ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 54                ARGENTINA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 55                COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 56                COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 57                COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 58                COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 59                COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 60                COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 61                COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 62                COLOMBIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 63                REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 64                REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 65                REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 66                REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 67                REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 68                REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 69                REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 70                REST OF SOUTH AMERICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 71                ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 72                ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (THOUSAND UNIT), 2020-2029

TABLE 73                INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (INDIAD MILLIONS), 2020-2029

TABLE 74                INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 75                INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (INDIAD MILLIONS), 2020-2029

TABLE 76                INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 77                INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (INDIAD MILLIONS), 2020-2029

TABLE 78                INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 79                INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (INDIAD MILLIONS), 2020-2029

TABLE 80                INDIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 81                CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 82                CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 83                CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 84                CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 85                CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 86                CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 87                CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 88                CHINA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 89                JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 90                JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 91                JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 92                JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 93                JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 94                JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 95                JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 96                JAPAN GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 97                SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 98                SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 99                SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 100              SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 101              SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 102              SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 103              SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 104              SOUTH KOREA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 105              AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 106              AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 107              AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 108              AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 109              AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 110              AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 111              AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 112              AUSTRALIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 113              SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 114              SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 115              SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 116              SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 117              SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 118              SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 119              SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 120              SOUTH EAST ASIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 121              REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 122              REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 123              REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 124              REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 125              REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 126              REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 127              REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 128              REST OF ASIA PACIFIC GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 129              EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 130              EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (THOUSAND UNIT), 2020-2029

TABLE 131              GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 132              GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 133              GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 134              GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 135              GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 136              GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 137              GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 138              GERMANY GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 139              UK GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 140              UK GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 141              UK GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 142              UK GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 143              UK GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 144              UK GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 145              UK GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 146              UK GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 147              FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 148              FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 149              FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 150              FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 151              FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 152              FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 153              FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 154              FRANCE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 155              ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 156              ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 157              ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 158              ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 159              ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 160              ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 161              ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 162              ITALY GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 163              SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 164              SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 165              SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 166              SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 167              SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 168              SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 169              SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 170              SPAIN GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 171              RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 172              RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 173              RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 174              RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 175              RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 176              RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 177              RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 178              RUSSIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 179              REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 180              REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 181              REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 182              REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 183              REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 184              REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 185              REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 186              REST OF EUROPE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 187              MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 188              MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY COUNTRY (THOUSAND UNIT), 2020-2029

TABLE 189              UAE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (UAED MILLIONS), 2020-2029

TABLE 190              UAE GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 191              UAE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (UAED MILLIONS), 2020-2029

TABLE 192              UAE GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 193              UAE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (UAED MILLIONS), 2020-2029

TABLE 194              UAE GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 195              UAE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (UAED MILLIONS), 2020-2029

TABLE 196              UAE GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 197              SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 198              SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 199              SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 200              SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 201              SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 202              SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 203              SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 204              SAUDI ARABIA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 205              SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 206              SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 207              SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 208              SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 209              SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 210              SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 211              SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 212              SOUTH AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

TABLE 213              REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (USD MILLIONS), 2020-2029

TABLE 214              REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM (THOUSAND UNIT), 2020-2029

TABLE 215              REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 216              REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE (THOUSAND UNIT), 2020-2029

TABLE 217              REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 218              REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY END USER (THOUSAND UNIT), 2020-2029

TABLE 219              REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 220              REST OF MIDDLE EAST & AFRICA GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION (THOUSAND UNIT), 2020-2029

LIST OF FIGURES

FIGURE 1               MARKET DYNAMICS

FIGURE 2               MARKET SEGMENTATION

FIGURE 3               REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4               DATA TRIANGULATION

FIGURE 5               BOTTOM-UP APPROACH

FIGURE 6               TOP-DOWN APPROACH

FIGURE 7               RESEARCH FLOW

FIGURE 8               GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM, USD MILLION, 2020-2029

FIGURE 9               GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE, USD MILLION, 2020-2029

FIGURE 10             GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER, USD MILLION, 2020-2029

FIGURE 11             GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION, USD MILLION, 2020-2029

FIGURE 12             GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 13             PORTER’S FIVE FORCES MODEL

FIGURE 14             GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY DOSAGE FORM, USD MILLION, 2020-2029

FIGURE 15             GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY TYPE, USD MILLION, 2020-2029

FIGURE 16             GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY END USER, USD MILLION, 2020-2029

FIGURE 17             GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY APPLICATION, USD MILLION, 2020-2029

FIGURE 18             GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 19             GASTROINTESTINAL THERAPEUTICS MARKET BY REGION 2020

FIGURE 20             MARKET SHARE ANALYSIS

FIGURE 21             ABBOTT LABORATORIES: COMPANY SNAPSHOT

FIGURE 22             JOHNSON & JOHNSON: COMPANY SNAPSHOT

FIGURE 23             ABBVIE INC.: COMPANY SNAPSHOT

FIGURE 24             SALIX PHARMACEUTICALS: COMPANY SNAPSHOT

FIGURE 25             GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT

FIGURE 26             ALLERGAN: COMPANY SNAPSHOT

FIGURE 27             TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT

FIGURE 28             ASTRAZENECA: COMPANY SNAPSHOT

FIGURE 29             ASTELLAS PHARMA USINC.: COMPANY SNAPSHOT

FIGURE 30             PFIZER AC: COMPANY SNAPSHOT

Identifying Key Products in the Market

The identification of key products in any market is pivotal for understanding what drives consumer interest, technological innovation, and competitive advantage. Here’s how to approach this:
Market Analysis Reports: Start with syndicated market analysis reports from firms like Nielsen, Euromonitor, or specialized industry analysts. These reports often highlight leading products based on sales data, innovation, and consumer feedback.
Patent Filings: Reviewing patent filings can provide insight into technological innovations and future products that may impact the market. Databases like the United States Patent and Trademark Office (USPTO) or the World Intellectual Property Organization (WIPO) can be invaluable.
Ecommerce Platforms and Retailer Websites: Analyzing bestselling products and customer reviews on platforms such as Amazon, Flipkart, or direct retailer websites can offer direct insights into consumer preferences and product popularity.
Consumer Surveys and Feedback: Conducting surveys or analyzing online forums and social media can reveal consumer preferences, pain points, and desired features in products. Tools like SurveyMonkey, Google Surveys, or social listening platforms can facilitate this process.

Segmenting the Market and Products

Market and product segmentation is crucial for targeting marketing efforts and product development. Here’s a methodology for segmenting based on technical specifications:
Technical Specifications Review: Compile a comprehensive list of products within the market, focusing on their technical specifications. This could involve processor speeds for electronics, ingredients for food products, or material composition for apparel.
Factor Analysis: Use statistical techniques like factor analysis to group products based on shared technical specifications. This method helps identify underlying relationships between different specifications and how they cluster together.
Expert Consultation: Engage with industry experts or technical specialists to ensure that the segmentation makes sense from both a market and a technical perspective. This step ensures the practical relevance of the segments identified.

Identifying and Classifying Key Application Segments

Understanding how products are used in different applications is essential for market strategy:
Use Case Analysis: Identify common use cases for products by reviewing product literature, customer testimonials, and case studies. This helps understand the variety of applications each product serves.
Industry Surveys: Conduct surveys targeting professionals in the field to understand how and why certain products are preferred in specific applications. This can also reveal unmet needs in the market.
ApplicationBased Segmentation: Group products based on their primary applications, considering factors such as industry use, consumer vs. professional use, and environmental conditions.

Calculating Market Size Using TopDown and BottomUp Approaches

Estimating the market size accurately is fundamental for strategic planning:
TopDown Approach: Start with global industry data and narrow down to the target market by applying known market shares or segmentation percentages. Industry reports and financial databases are key sources for this approach.
BottomUp Approach: Aggregate sales data or unit shipments from all known market participants. This might require gathering data from company reports, industry associations, and sales channels.
Combining Approaches: Validate the market size estimates by comparing the results from both approaches. Discrepancies can highlight areas requiring further investigation.

Calculating the CAGR for the Market

The Compound Annual Growth Rate (CAGR) is a useful measure to understand market growth over time:
Historical Sales Data: Gather historical sales or market size data over a defined period. Public company filings, industry reports, and government databases can be sources for this data.
CAGR Formula: Apply the CAGR formula \[CAGR = (EV/BV)^{1/n} 1\], where EV is the end value, BV is the beginning value, and n is the number of periods.
Segment and Overall Market CAGR: Calculate CAGR for both the overall market and individual segments to understand growth patterns.

Sources for Secondary or Desk Research

Identifying the right sources is crucial for accurate desk research:
Industry and Market Research Reports: Sources like IBISWorld, Statista, and Frost & Sullivan offer comprehensive industry reports.
Government and International Organizations: Websites of the U.S. Census Bureau, World Bank, and OECD provide economic and industry specific data.
Academic Journals: Platforms like Google Scholar and JSTOR can offer peer reviewed articles on market trends and consumer behavior.
News Archives and Trade Publications: Stay informed on industry developments through sources like Bloomberg, Reuters, and specific trade journals relevant to the market in question.
Each of these steps requires careful consideration and a systematic approach to ensure that the market research report is robust, insightful, and actionable.

Gastrointestinal Therapeutics Market

Base Year Value ()

CAGR ()

Forecast Year Value ()

Historical Data Period

Largest Region

Forecast Period

Instant access to hundreds of data points and trends

Descripción general del mercado de terapias gastrointestinales

Gastrointestinal Therapeutics Market Segment Analysis

Gastrointestinal Therapeutics Market Players

Who Should Buy? Or Key Stakeholders

Key Takeaways:

Gastrointestinal Therapeutics Market Regional Analysis

Key Market Segments: Gastrointestinal Therapeutics Market

Key Question Answered

LISTA DE TABLAS

LIST OF FIGURES

DOWNLOAD FREE SAMPLE REPORT

License Type

Get Sample to Email

SPEAK WITH OUR ANALYST

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

Talk to Expert

+1 (704) 266-3234

Send an Email

Contact us

Quick Links

We accept